A new class of nitric oxide donors


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

This article deals with a new class of nitric oxide donors—safe medications for the treatment of socially significant diseases. This complex work has been performed in collaboration with a number of RAS institutes, the Russian Cardiology Research and Production Complex, and the Blokhin Russian Cancer Research Center.

作者简介

S. Aldoshin

Institute of Problems of Chemical Physics

编辑信件的主要联系方式.
Email: smaldoshin@presidium.ras.ru
俄罗斯联邦, Chernogolovka, Moscow oblast

N. Sanina

Institute of Problems of Chemical Physics

Email: smaldoshin@presidium.ras.ru
俄罗斯联邦, Chernogolovka, Moscow oblast

M. Davydov

Blokhin Russian Cancer Research Center

Email: smaldoshin@presidium.ras.ru
俄罗斯联邦, Moscow

E. Chazov

Russian Cardiology Research and Production Complex

Email: smaldoshin@presidium.ras.ru
俄罗斯联邦, Moscow


版权所有 © Pleiades Publishing, Ltd., 2016
##common.cookie##